In humans, the risk variants of apolipoprotein-1 (APOL1) increase the lifetime risk of untreated HIV+ people developing HIVAN by ∼50% (Genovese et al., 2010; Kopp and Winkler, 2003; Kasembeli et al., 2015). The gene discussed is APOL1; the disease is HIV-associated nephropathy.